Negative control for Borussertib, being >1000 fold less potent in vitro than Borussertib

Clickable Remodelin analog

Prodrug of RO5203548, a selective agonist of the trace amine-associated receptor 1 (TAAR1)

Novel Orally Bioavailable Prodrug of Boronic Acid β-Lactamase Inhibitor QPX7728

An isomer of PU-H54, a novel Grp94- and Hsp90-selective inhibitor

Prodrug of DMOCPTL

Negative control for Primordazine A and Primordazine B

Negative control for PPTN

Less active enantiomer of LGH447, acting as a selective weak pan-PIM inhibitor (IC 50 (µM): PIM1 0.095; PIM2 0.522; PIM3 0.369) in comparision with LGH447 (IC 50 (µM): PIM1 0.001; PIM2 0.002; PIM3 0.002)

Deuterated internal standard for PhIP

Negative control for PFI-6

Negative control for PFI-653

Metabolite of PF-04691502, a highly potent and selective ATP competitive kinase inhibitor of class 1 PI3Ks and mTOR

Pro-drug of furamidine, acting as antiprotozoal/antifungal agent

Novel PA-9 analog, acting as an antagonist of the PAC1 receptor, showing improved antagonistic activities than PA-9

Prodrug of antitumor agent oncrasin-72, with improved stability, pharmacokinetics, and safety

Novel potent and highly selective KDM1A chemoprobe, exhibiting a selectivity profile similar to the parent compound ORY-1001

PET Precursor of VU0467485

Negative control for NVS-MLLT-1

Nagative control for NVS-BPTF-1

Prodrug of NUC013, a novel DNA methytransferase inhibitor

Negative control for Homer

The negative control compound for ML323

Novel Highly Selective Inhibitor of Methyltransferase DOT1L, being more metabolically stable and significantly less toxic in vivo than pinometostat

Novel potent antitubercular agent, inhibiting decaprenylphosphoryl-β-d-ribose 2'-oxidase (DprE1), displaying better aqueous solubility and metabolic stability than PBTZ169

Negative control for MDC-4381

Negative control for MS4322

Negative control for MS154

Prodrug of MRS4738, dramatically reducing lung inflammation in a mouse asthma model